{"member_organisations": "None", "identification_number": "42561875992-94", "fields_of_interest": "General and Institutional Affairs, Economy, finance and the euro, Trade, Competition, Customs, Business and Industry, Environment, Justice and Fundamental Rights, Single market, Research and innovation, Public Health", "head_office_address": "1 Francis Crick Avenue Cambridge Biomedical Campus", "full_time_equivalent_fte": "2", "person_with_legal_responsibility": "Pascal Soriot", "financial_year_start_date": "01/01/2017", "grants": "", "country_code": "GB", "head_office_country": "United Kingdom", "eu_initiatives": "Data Protection Regulation \nPharmacetical Industry Strategy \nPharmaceutical Incentives (IP) and regulation \nHealth Technology Assessment  \nSeasonal Infuenza \nPersonalised Medicine \nSustainable Health Care \nResearch policy & programmes  (IMI) \nTrade Policy \nBrexit", "level_of_interest": "global", "organisation_name": "AstraZeneca (AZ)", "belgium_office_post_code": "1000", "procurement": "", "section": "II - In-house lobbyists and trade/business/professional associations", "lon": 0.1340485, "source": "", "belgium_office_address": "AstraZeneca Square de Meeus 37", "belgium_office_phone": "(+32)496693430", "number_of_ep_accredited_persons": "1", "overall_budget_turnover_as_a_range": "", "subsection": "Companies & groups", "no_geo_reference": true, "persons_accredited_for_access_to_european_parliament_premises": "GOBBI#Talita", "estimate_of_costs_absolute_amount": "", "registration_date": "07/06/2011", "website_address": "http://www.astrazeneca.com", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Cambridge", "membership": "AstraZeneca is a member of the following organisations in Brussels which spend part of their time in defined activities: European Federation of Pharmaceutical Industries and Associations (EFPIA), European Biopharmaceutical Enterprises (EBE), American Chamber of Commerce to the EU (AmCham EU), Vaccines Europe (VE) and the European Alliance for Personalised Medicine (EAPM) \n \nLinks to these Trade associations are: \nhttp://www.efpia.eu/ \nhttp://www.ebe-biopharma.eu/ \nhttp://www.vaccineseurope.eu/ \nhttp://www.euapm.eu/ \nhttp://www.amchameu.eu/", "head_office_post_code": "CB2 0AA", "goals__remit": "AZ is a global research-based biopharmaceutical company headquartered in the UK. Our skills and resources are focused on discovering, developing and marketing medicines for some of the world\u2019s most serious illnesses, including cancer, diabetes, cardiovacular and respiratory disease. We employ over 59 000 people globally, with 15 000 involved in manufacturing, research and development and commercial activites throughout Europe.", "industry_forums": "", "inter_groups": "", "number_of_persons_involved": "4", "relevant_communication": "None", "financial_year_end_date": "01/12/2017", "lat": 52.1748061, "estimate_of_costs_as_a_range": "700000-799999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "Corporation", "person_in_charge_of_eu_relations": "Jennifer Shum", "customers": "", "belgium_office_post_box": "", "position": "Director EU Government Affairs", "belgium_office_city": "Brussels", "head_office_phone": "(+44)2037495000"}